Intellia Therapeutics (NTLA) Net Margin (QoQ) (2015 - 2026)
Intellia Therapeutics (NTLA) Net Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87,608.00 |
| Dec 31, 2025 | 121,286.00 |
| Sep 30, 2025 | -78,382.00 |
| Jun 30, 2025 | 70,326.00 |
| Mar 31, 2025 | -55,069.00 |
| Dec 31, 2024 | 59,683.00 |
| Sep 30, 2024 | 46,806.00 |
| Jun 30, 2024 | -160,164.00 |
| Mar 31, 2024 | -896,719.00 |
| Dec 31, 2023 | 984,050.00 |
| Sep 30, 2023 | 6,617.00 |
| Jun 30, 2023 | -12,114.00 |
| Mar 31, 2023 | -46,435.00 |
| Dec 31, 2022 | 86,301.00 |
| Sep 30, 2022 | -21,214.00 |
| Jun 30, 2022 | 164,722.00 |
| Mar 31, 2022 | -245,967.00 |
| Dec 31, 2021 | 871,174.00 |
| Sep 30, 2021 | 657,792.00 |
| Jun 30, 2021 | -879,889.00 |